KB
Kishore Bhooraram Choudhary
About Kishore Bhooraram Choudhary
Data last updated:
Kishore Bhooraram Choudhary is a Director at Riccur Pharma Private Limited (since 2020), Director at Vivaan Chemindia Private Limited (since 2016) and Designated Partner at Vivaan Prime Properties Llp (since 2017), and holds 1 more current directorship. The companies operate in Pharma, Real Estate and Construction and Business Outsourcing. The 2 current companies with reported revenue have a combined latest revenue of ₹25.66 Cr; the largest is Riccur Pharma Private Limited at ₹13.30 Cr (FY 2019). Earlier, Kishore Bhooraram Choudhary was a Director at Medichem Life Sciences Private Limited (2012–2015) and Additional Director at Metrix Healthcare Private Limited (2013) and 7 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Mar 2020 | 2011 | ₹13.30 Cr (FY 2019) | Active | |
| Director | 25 Feb 2016 | 2016 | ₹12.36 Cr (FY 2019) | Active | |
| Designated Partner | 28 Jun 2017 | 2017 | Active | ||
| Director | 02 Mar 2016 | 2016 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Oct 2012 | 2007 | Active | ||
| Additional Director | 19 Jan 2013 | 2004 | ₹51.51 Cr (FY 2017) | Active | |
| Director | 30 Dec 2011 | 2009 | Strike Off | ||
| Director | 31 Dec 2011 | 2000 | ₹5,926 (FY 2024) | Active | |
| Director | 14 Feb 2014 | 2004 | ₹64 Lakh (FY 2017) | Active | |
| Director | 23 May 2018 | 2018 | ₹18.7 Lakh (FY 2022) | Active | |
| Additional Director | 27 Sep 2012 | 2012 | ₹3.73 Cr (FY 2017) | Strike Off | |
| Director | 05 Jun 2012 | 2012 | ₹4.50 Cr (FY 2019) | Active | |
| Additional Director | 24 Nov 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kishore Bhooraram Choudhary
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sundarpalsing Dharamveer Arneja | 08110744 | Riccur Pharma Private Limited | Director |
| Kamla Kishore Choudhary | 05118145 | Vivaan Chemindia Private Limited , Vivaan Bhoomi Private Limited | Director |
| Nitin Raghunath Jadhav | 07671495 | Vivaan Prime Properties Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kishore Bhooraram Choudhary
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kishore Bhooraram Choudhary
Kishore Bhooraram Choudhary currently holds 4 directorships: Riccur Pharma Private Limited (Director, since 17 Mar 2020, revenue ₹13.30 Cr (FY 2019)); Vivaan Chemindia Private Limited (Director, since 25 Feb 2016, revenue ₹12.36 Cr (FY 2019)); Vivaan Prime Properties Llp (Designated Partner, since 28 Jun 2017); Vivaan Bhoomi Private Limited (Director, since 02 Mar 2016).
Kishore Bhooraram Choudhary was first appointed on 24 Nov 2011 as Additional Director at Omkar Global Corporation Private Limited. The most recent appointment on record is 17 Mar 2020 at Riccur Pharma Private Limited.
The 2 current companies of Kishore Bhooraram Choudhary that report revenue have a combined latest revenue of ₹25.66 Cr: Riccur Pharma Private Limited ₹13.30 Cr (FY 2019); Vivaan Chemindia Private Limited ₹12.36 Cr (FY 2019).
Kishore Bhooraram Choudhary held 9 earlier board appointments: Medichem Life Sciences Private Limited (Director, 01 Oct 2012 to 08 Dec 2015); Metrix Healthcare Private Limited (Additional Director, 19 Jan 2013 to 18 Mar 2013); Ramkripa Developers Private Limited (Director, 30 Dec 2011 to 30 Apr 2012); Red Rose Granites Private Limited (Director, 31 Dec 2011 to 30 Apr 2012); Syglak Laboratories Private Limited (Director, 14 Feb 2014 to 23 Aug 2016); and 4 more.
The current boards of Kishore Bhooraram Choudhary's companies include Sundarpalsing Dharamveer Arneja (Riccur Pharma Private Limited), Kamla Kishore Choudhary (Vivaan Chemindia Private Limited), Nitin Raghunath Jadhav (Vivaan Prime Properties Llp).